BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26246524)

  • 21. Unilateral cancer-associated retinopathy: diagnosis, serology and treatment.
    Roels D; Ueno S; Talianu CD; Draganova D; Kondo M; Leroy BP
    Doc Ophthalmol; 2017 Dec; 135(3):233-240. PubMed ID: 28815346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes Associated With Sustained-Release Intraocular Fluocinolone Implants in a Case of Melanoma-Associated Retinopathy Treated Without Systemic Immunosuppression.
    Karatsai E; Robson AG; Taylor SRJ
    JAMA Ophthalmol; 2019 May; 137(5):564-567. PubMed ID: 30896772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases.
    Guy J; Aptsiauri N
    Arch Ophthalmol; 1999 Apr; 117(4):471-7. PubMed ID: 10206574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of melanoma-associated retinopathy with autoantibodies against TRPM1.
    Kim MS; Hong HK; Ko YJ; Park KH; Ueno S; Okado S; Woo SJ; Joo K
    Doc Ophthalmol; 2020 Dec; 141(3):313-318. PubMed ID: 32472235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paraneoplastic retinopathy: a novel autoantibody reaction associated with small-cell lung carcinoma.
    Murphy MA; Thirkill CE; Hart WM
    J Neuroophthalmol; 1997 Jun; 17(2):77-83. PubMed ID: 9176775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination Treatment with Rituximab and Bortezomib in a Patient with Non-Paraneoplastic Autoimmune Retinopathy.
    Benson MD; Plemel DJA; Yacyshyn E; Sandhu I; MacDonald IM; Baker CF
    Ocul Immunol Inflamm; 2020 Aug; 28(6):958-965. PubMed ID: 31418623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute progressive paravascular placoid neuroretinopathy with negative-type electroretinography in paraneoplastic retinopathy.
    Chen FK; Chew AL; Zhang D; Chen SC; Chelva E; Chandrasekera E; Koay EMH; Forrester J; McLenachan S
    Doc Ophthalmol; 2017 Jun; 134(3):227-235. PubMed ID: 28382556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Paraneoplastic retinopathy].
    Liu Y; Lei B
    Zhonghua Yan Ke Za Zhi; 2012 Jul; 48(7):653-6. PubMed ID: 22943872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Slowly progressive non-neoplastic autoimmune-like retinopathy.
    Ohta K; Kikuchi T; Yoshida N
    Graefes Arch Clin Exp Ophthalmol; 2011 Jan; 249(1):155-8. PubMed ID: 20625760
    [No Abstract]   [Full Text] [Related]  

  • 30. Autoimmune retinopathy in the absence of cancer.
    Mizener JB; Kimura AE; Adamus G; Thirkill CE; Goeken JA; Kardon RH
    Am J Ophthalmol; 1997 May; 123(5):607-18. PubMed ID: 9152066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paraneoplastic and non-paraneoplastic retinopathy and optic neuropathy: evaluation and management.
    Rahimy E; Sarraf D
    Surv Ophthalmol; 2013; 58(5):430-58. PubMed ID: 23969019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thyroid malignancy presenting with visual loss: an unusual case of paraneoplastic retinopathy.
    Hughes E; Moran S; Flitcroft I; Logan P
    BMJ Case Rep; 2016 Oct; 2016():. PubMed ID: 27797800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paraneoplastic ocular syndrome: a pandora's box of underlying malignancies.
    Sarkar P; Mehtani A; Gandhi HC; Bhalla JS; Tapariya S
    Eye (Lond); 2022 Jul; 36(7):1355-1367. PubMed ID: 34345027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Latest updates on antiretinal autoantibodies associated with vision loss and breast cancer.
    Adamus G
    Invest Ophthalmol Vis Sci; 2015 Mar; 56(3):1680-8. PubMed ID: 25754855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case report of acute zonal occult outer retinopathy.
    Kaye R; De Salvo G
    Eur J Ophthalmol; 2019 Jul; 29(1_suppl):27-31. PubMed ID: 31282209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A case of paraneoplastic retinopathy with serum antibody against retinal soluble 70 kDa protein].
    Takahashi K; Suzuki J; Ohguro H; Ohyachi H; Yoshida K; Takahashi H; Nakagawa T
    Nippon Ganka Gakkai Zasshi; 1997 Jan; 101(1):92-6. PubMed ID: 9028114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unusual paraneoplastic cause of vision loss: combined paraneoplastic cone dystrophy and optic neuropathy.
    Finger ML; Thirkill CE; Borruat FX
    Arch Ophthalmol; 2012 May; 130(5):660-2. PubMed ID: 22652860
    [No Abstract]   [Full Text] [Related]  

  • 38. [CAR syndrome (carcinoma-associated retinopathy syndrome) associated with an adenocarcinoma of the cervix].
    Seles S; Lang GE
    Klin Monbl Augenheilkd; 2005 Sep; 222(9):736-9. PubMed ID: 16175485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cystoid macular edema from cancer-associated retinopathy.
    Moyer K; DeWilde A; Law C
    Optom Vis Sci; 2014 Apr; 91(4 Suppl 1):S66-70. PubMed ID: 24531653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The photoreceptor cell-specific nuclear receptor is an autoantigen of paraneoplastic retinopathy.
    Eichen JG; Dalmau J; Demopoulos A; Wade D; Posner JB; Rosenfeld MR
    J Neuroophthalmol; 2001 Sep; 21(3):168-72. PubMed ID: 11725181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.